

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.14608049 |
| 2 | muscle filament sliding (GO:0030049) | 8.44706167 |
| 3 | actin-myosin filament sliding (GO:0033275) | 8.44706167 |
| 4 | cardiac myofibril assembly (GO:0055003) | 7.88370850 |
| 5 | myofibril assembly (GO:0030239) | 7.69818305 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.63751409 |
| 7 | regulation of skeletal muscle contraction (GO:0014819) | 7.38010894 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.19865290 |
| 9 | actin-mediated cell contraction (GO:0070252) | 7.03423894 |
| 10 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.78704813 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.77650298 |
| 12 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.68425031 |
| 13 | plasma membrane repair (GO:0001778) | 6.65331681 |
| 14 | cardiac muscle contraction (GO:0060048) | 6.37528878 |
| 15 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.25936131 |
| 16 | regulation of relaxation of muscle (GO:1901077) | 6.16794608 |
| 17 | tricarboxylic acid cycle (GO:0006099) | 6.14384429 |
| 18 | cardiac muscle cell development (GO:0055013) | 5.95231012 |
| 19 | regulation of actin filament-based movement (GO:1903115) | 5.90618433 |
| 20 | actomyosin structure organization (GO:0031032) | 5.79211965 |
| 21 | striated muscle contraction (GO:0006941) | 5.76939652 |
| 22 | cardiac cell development (GO:0055006) | 5.58764437 |
| 23 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.57106079 |
| 24 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.56214163 |
| 25 | carnitine shuttle (GO:0006853) | 5.51429535 |
| 26 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.50716603 |
| 27 | regulation of cell communication by electrical coupling (GO:0010649) | 5.46846360 |
| 28 | skeletal muscle contraction (GO:0003009) | 5.38910017 |
| 29 | actin filament-based movement (GO:0030048) | 5.30129920 |
| 30 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.24529266 |
| 31 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.19397492 |
| 32 | cardiac muscle hypertrophy (GO:0003300) | 5.17216402 |
| 33 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.10749447 |
| 34 | regulation of sarcomere organization (GO:0060297) | 5.06682697 |
| 35 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.06025937 |
| 36 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.03397402 |
| 37 | striated muscle hypertrophy (GO:0014897) | 4.97782238 |
| 38 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.96802849 |
| 39 | adult heart development (GO:0007512) | 4.92542757 |
| 40 | regulation of striated muscle contraction (GO:0006942) | 4.90645563 |
| 41 | fatty acid transmembrane transport (GO:1902001) | 4.75445941 |
| 42 | muscle tissue morphogenesis (GO:0060415) | 4.69694012 |
| 43 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.68648753 |
| 44 | heart trabecula formation (GO:0060347) | 4.61594840 |
| 45 | heart process (GO:0003015) | 4.59546130 |
| 46 | heart contraction (GO:0060047) | 4.59546130 |
| 47 | regulation of cofactor metabolic process (GO:0051193) | 4.56538886 |
| 48 | regulation of coenzyme metabolic process (GO:0051196) | 4.56538886 |
| 49 | creatine metabolic process (GO:0006600) | 4.47566823 |
| 50 | regulation of membrane repolarization (GO:0060306) | 4.44195387 |
| 51 | muscle hypertrophy (GO:0014896) | 4.40395590 |
| 52 | skeletal muscle adaptation (GO:0043501) | 4.26829262 |
| 53 | cell communication involved in cardiac conduction (GO:0086065) | 4.12798701 |
| 54 | carnitine transmembrane transport (GO:1902603) | 4.08580886 |
| 55 | * muscle contraction (GO:0006936) | 4.02476570 |
| 56 | response to inactivity (GO:0014854) | 4.02073687 |
| 57 | regulation of the force of heart contraction (GO:0002026) | 3.99648790 |
| 58 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.95901130 |
| 59 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.91231626 |
| 60 | striated muscle adaptation (GO:0014888) | 3.86200870 |
| 61 | skeletal muscle fiber development (GO:0048741) | 3.85083217 |
| 62 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.83804579 |
| 63 | regulation of cardiac muscle contraction (GO:0055117) | 3.82123305 |
| 64 | striated muscle cell development (GO:0055002) | 3.81949368 |
| 65 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.81277387 |
| 66 | response to epinephrine (GO:0071871) | 3.80595239 |
| 67 | detection of calcium ion (GO:0005513) | 3.80400603 |
| 68 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.80387435 |
| 69 | muscle hypertrophy in response to stress (GO:0003299) | 3.80387435 |
| 70 | cardiac muscle adaptation (GO:0014887) | 3.80387435 |
| 71 | NADH metabolic process (GO:0006734) | 3.80054050 |
| 72 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.76147716 |
| 73 | negative regulation of protein localization to cell surface (GO:2000009) | 3.75994303 |
| 74 | * muscle system process (GO:0003012) | 3.75546706 |
| 75 | 2-oxoglutarate metabolic process (GO:0006103) | 3.75235990 |
| 76 | regulation of sulfur metabolic process (GO:0042762) | 3.73884186 |
| 77 | carnitine transport (GO:0015879) | 3.71301367 |
| 78 | amino-acid betaine transport (GO:0015838) | 3.71301367 |
| 79 | response to caffeine (GO:0031000) | 3.69677994 |
| 80 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.69328907 |
| 81 | cardiac muscle cell action potential (GO:0086001) | 3.69111156 |
| 82 | myotube cell development (GO:0014904) | 3.69009407 |
| 83 | negative regulation of potassium ion transport (GO:0043267) | 3.67376833 |
| 84 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.64743142 |
| 85 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.64230807 |
| 86 | regulation of heart rate (GO:0002027) | 3.62913437 |
| 87 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.62877577 |
| 88 | regulation of ATP catabolic process (GO:1903289) | 3.62778285 |
| 89 | regulation of ATPase activity (GO:0043462) | 3.62778285 |
| 90 | muscle adaptation (GO:0043500) | 3.61261692 |
| 91 | cellular response to epinephrine stimulus (GO:0071872) | 3.60934790 |
| 92 | regulation of muscle system process (GO:0090257) | 3.60373091 |
| 93 | regulation of sequestering of triglyceride (GO:0010889) | 3.58140887 |
| 94 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.57815132 |
| 95 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.57815132 |
| 96 | relaxation of cardiac muscle (GO:0055119) | 3.53898924 |
| 97 | skeletal muscle tissue development (GO:0007519) | 3.53274241 |
| 98 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.52860860 |
| 99 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.52860860 |
| 100 | muscle atrophy (GO:0014889) | 3.52593793 |
| 101 | response to muscle activity (GO:0014850) | 3.50907195 |
| 102 | respiratory electron transport chain (GO:0022904) | 3.47706589 |
| 103 | striated muscle atrophy (GO:0014891) | 3.45650166 |
| 104 | positive regulation of cation channel activity (GO:2001259) | 3.44629783 |
| 105 | oxidative phosphorylation (GO:0006119) | 3.43847222 |
| 106 | muscle cell cellular homeostasis (GO:0046716) | 3.43438786 |
| 107 | glycogen catabolic process (GO:0005980) | 3.42972442 |
| 108 | muscle fiber development (GO:0048747) | 3.39949097 |
| 109 | regulation of muscle contraction (GO:0006937) | 3.37381350 |
| 110 | electron transport chain (GO:0022900) | 3.36563393 |
| 111 | cell communication by electrical coupling (GO:0010644) | 3.35838454 |
| 112 | regulation of heart contraction (GO:0008016) | 3.34619912 |
| 113 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.33379170 |
| 114 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.32872902 |
| 115 | ATP synthesis coupled proton transport (GO:0015986) | 3.32872902 |
| 116 | oxygen transport (GO:0015671) | 3.30389105 |
| 117 | positive regulation of heart rate (GO:0010460) | 3.29831172 |
| 118 | glycogen biosynthetic process (GO:0005978) | 3.28090021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.28671746 |
| 2 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.47708816 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.17365556 |
| 4 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.06102557 |
| 5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.06102557 |
| 6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.00862962 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.85463742 |
| 8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.33057675 |
| 9 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.11469212 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.02218677 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.93777247 |
| 12 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.66438543 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.55236138 |
| 14 | * EZH2_22144423_ChIP-Seq_EOC_Human | 2.42950151 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.28575438 |
| 16 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.21125879 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.10385179 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.98342227 |
| 19 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.89515241 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.87374123 |
| 21 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.75441644 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75059841 |
| 23 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.67378858 |
| 24 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.66885596 |
| 25 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.65384800 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.57088321 |
| 27 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53783970 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 1.43581743 |
| 29 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.41961714 |
| 30 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.37939896 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.35718459 |
| 32 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.31739118 |
| 33 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.29106508 |
| 34 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.29051356 |
| 35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29016083 |
| 36 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.27221195 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25012254 |
| 38 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23821412 |
| 39 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.23616693 |
| 40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.18847806 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18205176 |
| 42 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17605200 |
| 43 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.16133927 |
| 44 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.13416419 |
| 45 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13405892 |
| 46 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.13204056 |
| 47 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.12845545 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12175239 |
| 49 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12166493 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09955803 |
| 51 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09429689 |
| 52 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08004387 |
| 53 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07906763 |
| 54 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.07108037 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05968236 |
| 56 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.04039972 |
| 57 | CJUN_26792858_Chip-Seq_BT549_Human | 1.03844853 |
| 58 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03624422 |
| 59 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.02325680 |
| 60 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01192450 |
| 61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00303862 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99455037 |
| 63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.99406398 |
| 64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99127634 |
| 65 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98910542 |
| 66 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98172883 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98045363 |
| 68 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.97075926 |
| 69 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.96990776 |
| 70 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.96710518 |
| 71 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.96710518 |
| 72 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.96446950 |
| 73 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96370528 |
| 74 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95757094 |
| 75 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95605873 |
| 76 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.95256897 |
| 77 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.94930693 |
| 78 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94926931 |
| 79 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94127885 |
| 80 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93924869 |
| 81 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93483225 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92568401 |
| 83 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92390622 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91925838 |
| 85 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.91904797 |
| 86 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91654307 |
| 87 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.91540565 |
| 88 | P68_20966046_ChIP-Seq_HELA_Human | 0.91436546 |
| 89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91355048 |
| 90 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.90457432 |
| 91 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90421729 |
| 92 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89509910 |
| 93 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.89000163 |
| 94 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.88302077 |
| 95 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.88159577 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87240864 |
| 97 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.86828345 |
| 98 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86755341 |
| 99 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.86670654 |
| 100 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86634441 |
| 101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85285355 |
| 102 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85124340 |
| 103 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84709605 |
| 104 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84443006 |
| 105 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.83799876 |
| 106 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.83207844 |
| 107 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.83103995 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82789141 |
| 109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82123600 |
| 110 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82123600 |
| 111 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.81620580 |
| 112 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.81496123 |
| 113 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.81232608 |
| 114 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80871402 |
| 115 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.80226857 |
| 116 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.79297749 |
| 117 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.78667182 |
| 118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78636106 |
| 119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.78465353 |
| 120 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.78220171 |
| 121 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.78029118 |
| 122 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.77927975 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77903157 |
| 124 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.77702758 |
| 125 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.77555583 |
| 126 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.77540206 |
| 127 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.76320200 |
| 128 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.75795924 |
| 129 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.75692127 |
| 130 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.75463727 |
| 131 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.75314008 |
| 132 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.75230778 |
| 133 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.75131342 |
| 134 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.75068510 |
| 135 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.74365328 |
| 136 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.74360260 |
| 137 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.74199852 |
| 138 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73365026 |
| 139 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.73296393 |
| 140 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72822004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.66407406 |
| 2 | MP0003646_muscle_fatigue | 6.04815716 |
| 3 | MP0000751_myopathy | 5.50967299 |
| 4 | MP0004084_abnormal_cardiac_muscle | 5.30772177 |
| 5 | MP0000749_muscle_degeneration | 4.52299935 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.40185340 |
| 7 | MP0004215_abnormal_myocardial_fiber | 4.31907313 |
| 8 | MP0005330_cardiomyopathy | 3.61412650 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.38377346 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.27630713 |
| 11 | MP0000750_abnormal_muscle_regeneration | 3.00676576 |
| 12 | MP0002106_abnormal_muscle_physiology | 2.99449619 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.87603971 |
| 14 | MP0002972_abnormal_cardiac_muscle | 2.86890398 |
| 15 | MP0004130_abnormal_muscle_cell | 2.74183337 |
| 16 | MP0002269_muscular_atrophy | 2.64310977 |
| 17 | MP0008775_abnormal_heart_ventricle | 2.63256598 |
| 18 | MP0000747_muscle_weakness | 2.58392865 |
| 19 | MP0003137_abnormal_impulse_conducting | 2.53390680 |
| 20 | MP0005369_muscle_phenotype | 2.45345069 |
| 21 | MP0000759_abnormal_skeletal_muscle | 2.42811604 |
| 22 | MP0010630_abnormal_cardiac_muscle | 2.41113765 |
| 23 | MP0004484_altered_response_of | 2.38874320 |
| 24 | MP0005385_cardiovascular_system_phenoty | 2.38068561 |
| 25 | MP0001544_abnormal_cardiovascular_syste | 2.38068561 |
| 26 | MP0006138_congestive_heart_failure | 2.10637998 |
| 27 | MP0003828_pulmonary_edema | 1.94640864 |
| 28 | MP0004233_abnormal_muscle_weight | 1.88045146 |
| 29 | MP0004085_abnormal_heartbeat | 1.81353797 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.76348270 |
| 31 | MP0006036_abnormal_mitochondrial_physio | 1.70992207 |
| 32 | MP0004510_myositis | 1.69423206 |
| 33 | MP0002332_abnormal_exercise_endurance | 1.56080314 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.47745300 |
| 35 | MP0002127_abnormal_cardiovascular_syste | 1.44686010 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.43585200 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.21756859 |
| 38 | MP0005670_abnormal_white_adipose | 1.21078237 |
| 39 | MP0002108_abnormal_muscle_morphology | 1.17709937 |
| 40 | MP0000343_altered_response_to | 1.15314632 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.12837526 |
| 42 | MP0000266_abnormal_heart_morphology | 1.05684625 |
| 43 | MP0001661_extended_life_span | 1.05663919 |
| 44 | MP0003567_abnormal_fetal_cardiomyocyte | 1.05229059 |
| 45 | MP0000733_abnormal_muscle_development | 1.04258842 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.02340518 |
| 47 | MP0002234_abnormal_pharynx_morphology | 1.01350887 |
| 48 | MP0005165_increased_susceptibility_to | 0.98921213 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 0.93151717 |
| 50 | MP0003279_aneurysm | 0.91951129 |
| 51 | MP0004270_analgesia | 0.90188725 |
| 52 | MP0005623_abnormal_meninges_morphology | 0.85364354 |
| 53 | MP0000230_abnormal_systemic_arterial | 0.83683509 |
| 54 | MP0005266_abnormal_metabolism | 0.83598556 |
| 55 | MP0002128_abnormal_blood_circulation | 0.76467549 |
| 56 | MP0001879_abnormal_lymphatic_vessel | 0.74477870 |
| 57 | MP0002971_abnormal_brown_adipose | 0.73682641 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 0.68906644 |
| 59 | MP0003566_abnormal_cell_adhesion | 0.67317399 |
| 60 | MP0000013_abnormal_adipose_tissue | 0.66717074 |
| 61 | MP0009780_abnormal_chondrocyte_physiolo | 0.66346916 |
| 62 | MP0005275_abnormal_skin_tensile | 0.63701526 |
| 63 | MP0000767_abnormal_smooth_muscle | 0.63297677 |
| 64 | MP0004043_abnormal_pH_regulation | 0.61615472 |
| 65 | MP0000003_abnormal_adipose_tissue | 0.61199056 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 0.60335636 |
| 67 | MP0004272_abnormal_basement_membrane | 0.59809632 |
| 68 | MP0008438_abnormal_cutaneous_collagen | 0.53016016 |
| 69 | MP0005451_abnormal_body_composition | 0.52450006 |
| 70 | MP0008569_lethality_at_weaning | 0.51281578 |
| 71 | MP0005187_abnormal_penis_morphology | 0.50520379 |
| 72 | MP0008961_abnormal_basal_metabolism | 0.50169136 |
| 73 | MP0004147_increased_porphyrin_level | 0.46886262 |
| 74 | MP0002078_abnormal_glucose_homeostasis | 0.46774022 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 0.44724931 |
| 76 | MP0002638_abnormal_pupillary_reflex | 0.41906846 |
| 77 | MP0002909_abnormal_adrenal_gland | 0.41899954 |
| 78 | MP0002925_abnormal_cardiovascular_devel | 0.40747782 |
| 79 | MP0001614_abnormal_blood_vessel | 0.35892593 |
| 80 | MP0008004_abnormal_stomach_pH | 0.34777194 |
| 81 | MP0003879_abnormal_hair_cell | 0.34629674 |
| 82 | MP0001784_abnormal_fluid_regulation | 0.34258356 |
| 83 | MP0005334_abnormal_fat_pad | 0.32277523 |
| 84 | MP0000579_abnormal_nail_morphology | 0.32237665 |
| 85 | MP0003948_abnormal_gas_homeostasis | 0.31007054 |
| 86 | MP0003045_fibrosis | 0.30080068 |
| 87 | MP0001984_abnormal_olfaction | 0.30046413 |
| 88 | MP0009384_cardiac_valve_regurgitation | 0.28527455 |
| 89 | MP0005376_homeostasis/metabolism_phenot | 0.28069277 |
| 90 | MP0000372_irregular_coat_pigmentation | 0.27926033 |
| 91 | MP0005503_abnormal_tendon_morphology | 0.27733843 |
| 92 | MP0005535_abnormal_body_temperature | 0.27574149 |
| 93 | MP0002822_catalepsy | 0.25370033 |
| 94 | MP0003984_embryonic_growth_retardation | 0.24425070 |
| 95 | MP0009115_abnormal_fat_cell | 0.24206848 |
| 96 | MP0003941_abnormal_skin_development | 0.23793872 |
| 97 | MP0002088_abnormal_embryonic_growth/wei | 0.22935901 |
| 98 | MP0004142_abnormal_muscle_tone | 0.22505211 |
| 99 | MP0005595_abnormal_vascular_smooth | 0.21620538 |
| 100 | MP0004924_abnormal_behavior | 0.21557474 |
| 101 | MP0005386_behavior/neurological_phenoty | 0.21557474 |
| 102 | MP0009840_abnormal_foam_cell | 0.21429847 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 0.20966956 |
| 104 | MP0005166_decreased_susceptibility_to | 0.20686595 |
| 105 | MP0002118_abnormal_lipid_homeostasis | 0.19642258 |
| 106 | MP0005452_abnormal_adipose_tissue | 0.18924298 |
| 107 | MP0001299_abnormal_eye_distance/ | 0.18920526 |
| 108 | MP0008874_decreased_physiological_sensi | 0.18891215 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.18443628 |
| 110 | MP0003195_calcinosis | 0.18419381 |
| 111 | MP0001958_emphysema | 0.18098675 |
| 112 | MP0001727_abnormal_embryo_implantation | 0.18030176 |
| 113 | MP0003656_abnormal_erythrocyte_physiolo | 0.17902322 |
| 114 | MP0001853_heart_inflammation | 0.17417144 |
| 115 | MP0004134_abnormal_chest_morphology | 0.15886793 |
| 116 | MP0000249_abnormal_blood_vessel | 0.15609809 |
| 117 | MP0002066_abnormal_motor_capabilities/c | 0.15404309 |
| 118 | MP0005332_abnormal_amino_acid | 0.15352361 |
| 119 | MP0005423_abnormal_somatic_nervous | 0.15284291 |
| 120 | MP0002877_abnormal_melanocyte_morpholog | 0.15244769 |
| 121 | MP0000762_abnormal_tongue_morphology | 0.13314265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.27674827 |
| 2 | Exercise-induced myalgia (HP:0003738) | 6.98011182 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.84836540 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 6.70546197 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.61570913 |
| 6 | Muscle fiber splitting (HP:0003555) | 6.20463644 |
| 7 | Ventricular tachycardia (HP:0004756) | 6.11071433 |
| 8 | Abnormality of the calf musculature (HP:0001430) | 5.42433677 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 5.38000947 |
| 10 | Myoglobinuria (HP:0002913) | 5.30604539 |
| 11 | Atrial fibrillation (HP:0005110) | 5.09356004 |
| 12 | Muscle fiber inclusion bodies (HP:0100299) | 4.83633360 |
| 13 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.79211934 |
| 14 | Primary atrial arrhythmia (HP:0001692) | 4.75388249 |
| 15 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.73750074 |
| 16 | Subaortic stenosis (HP:0001682) | 4.73750074 |
| 17 | Lipoatrophy (HP:0100578) | 4.69127186 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 4.65008931 |
| 19 | Increased connective tissue (HP:0009025) | 4.59724782 |
| 20 | Supraventricular tachycardia (HP:0004755) | 4.59292222 |
| 21 | Right ventricular cardiomyopathy (HP:0011663) | 4.53490778 |
| 22 | Supraventricular arrhythmia (HP:0005115) | 4.50068139 |
| 23 | Difficulty running (HP:0009046) | 4.48758144 |
| 24 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.44411532 |
| 25 | Type 1 muscle fiber predominance (HP:0003803) | 4.17958135 |
| 26 | Rhabdomyolysis (HP:0003201) | 4.17620092 |
| 27 | Nemaline bodies (HP:0003798) | 4.12319061 |
| 28 | Bundle branch block (HP:0011710) | 4.04406581 |
| 29 | Syncope (HP:0001279) | 4.03742264 |
| 30 | Dilated cardiomyopathy (HP:0001644) | 4.02823276 |
| 31 | Myotonia (HP:0002486) | 3.83887974 |
| 32 | Asymmetric septal hypertrophy (HP:0001670) | 3.81059936 |
| 33 | Palpitations (HP:0001962) | 3.75700932 |
| 34 | Prolonged QT interval (HP:0001657) | 3.64408512 |
| 35 | Difficulty climbing stairs (HP:0003551) | 3.42666160 |
| 36 | Ventricular arrhythmia (HP:0004308) | 3.41868414 |
| 37 | Heart block (HP:0012722) | 3.40899564 |
| 38 | Distal arthrogryposis (HP:0005684) | 3.28284993 |
| 39 | Abnormal atrioventricular conduction (HP:0005150) | 3.23256780 |
| 40 | Atrioventricular block (HP:0001678) | 3.23000024 |
| 41 | Muscle stiffness (HP:0003552) | 3.14102555 |
| 42 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.12674953 |
| 43 | Increased variability in muscle fiber diameter (HP:0003557) | 3.11932419 |
| 44 | Ventricular fibrillation (HP:0001663) | 3.00907835 |
| 45 | Neck muscle weakness (HP:0000467) | 2.92087298 |
| 46 | Round ear (HP:0100830) | 2.91101399 |
| 47 | Myopathic facies (HP:0002058) | 2.89096008 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.88826085 |
| 49 | Areflexia of lower limbs (HP:0002522) | 2.85122390 |
| 50 | Deformed tarsal bones (HP:0008119) | 2.76366402 |
| 51 | Ragged-red muscle fibers (HP:0003200) | 2.71780999 |
| 52 | Rimmed vacuoles (HP:0003805) | 2.57448370 |
| 53 | Abnormal EKG (HP:0003115) | 2.57063038 |
| 54 | Limb-girdle muscle atrophy (HP:0003797) | 2.54549184 |
| 55 | Left ventricular hypertrophy (HP:0001712) | 2.54257762 |
| 56 | Hepatic necrosis (HP:0002605) | 2.45904013 |
| 57 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.36565704 |
| 58 | Ketoacidosis (HP:0001993) | 2.34124054 |
| 59 | Distal lower limb amyotrophy (HP:0008944) | 2.34019697 |
| 60 | Hypoplastic ischia (HP:0003175) | 2.33971586 |
| 61 | Palmoplantar keratoderma (HP:0000982) | 2.33237184 |
| 62 | Abnormal finger flexion creases (HP:0006143) | 2.33154581 |
| 63 | Gowers sign (HP:0003391) | 2.33067409 |
| 64 | Testicular atrophy (HP:0000029) | 2.33041233 |
| 65 | Generalized muscle weakness (HP:0003324) | 2.32866012 |
| 66 | Ulnar deviation of the wrist (HP:0003049) | 2.30878290 |
| 67 | Acute necrotizing encephalopathy (HP:0006965) | 2.29574739 |
| 68 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.26212592 |
| 69 | EMG: neuropathic changes (HP:0003445) | 2.25895481 |
| 70 | Muscular dystrophy (HP:0003560) | 2.23013964 |
| 71 | Fetal akinesia sequence (HP:0001989) | 2.19356972 |
| 72 | Weak cry (HP:0001612) | 2.15825662 |
| 73 | Facial diplegia (HP:0001349) | 2.15483133 |
| 74 | Lower limb amyotrophy (HP:0007210) | 2.13917831 |
| 75 | Increased muscle lipid content (HP:0009058) | 2.12412514 |
| 76 | Hepatocellular necrosis (HP:0001404) | 2.12198398 |
| 77 | Frequent falls (HP:0002359) | 2.08595057 |
| 78 | Hypoglycemic coma (HP:0001325) | 2.08402547 |
| 79 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.06211904 |
| 80 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.05600807 |
| 81 | Abnormality of the ischium (HP:0003174) | 2.03035573 |
| 82 | Scapular winging (HP:0003691) | 2.02534577 |
| 83 | Hip contracture (HP:0003273) | 1.97776410 |
| 84 | Acute encephalopathy (HP:0006846) | 1.97286032 |
| 85 | Dicarboxylic aciduria (HP:0003215) | 1.96774459 |
| 86 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.96774459 |
| 87 | Abnormality of the foot musculature (HP:0001436) | 1.96104580 |
| 88 | Exercise intolerance (HP:0003546) | 1.94779645 |
| 89 | Foot dorsiflexor weakness (HP:0009027) | 1.94167891 |
| 90 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.93504651 |
| 91 | Hyperkalemia (HP:0002153) | 1.92321712 |
| 92 | Waddling gait (HP:0002515) | 1.91520976 |
| 93 | Abnormality of alanine metabolism (HP:0010916) | 1.91041796 |
| 94 | Hyperalaninemia (HP:0003348) | 1.91041796 |
| 95 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.91041796 |
| 96 | Conjunctival hamartoma (HP:0100780) | 1.90081586 |
| 97 | Proximal amyotrophy (HP:0007126) | 1.89782935 |
| 98 | Abnormality of the neuromuscular junction (HP:0003398) | 1.88573217 |
| 99 | Fatigable weakness (HP:0003473) | 1.88573217 |
| 100 | Mitochondrial inheritance (HP:0001427) | 1.88295680 |
| 101 | Progressive macrocephaly (HP:0004481) | 1.88051867 |
| 102 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.87987278 |
| 103 | Steppage gait (HP:0003376) | 1.84759380 |
| 104 | Slender build (HP:0001533) | 1.84587944 |
| 105 | Increased intramyocellular lipid droplets (HP:0012240) | 1.84113372 |
| 106 | Absent phalangeal crease (HP:0006109) | 1.83956945 |
| 107 | Calcaneovalgus deformity (HP:0001848) | 1.83467234 |
| 108 | Spinal rigidity (HP:0003306) | 1.83330968 |
| 109 | Limb-girdle muscle weakness (HP:0003325) | 1.82963690 |
| 110 | Large for gestational age (HP:0001520) | 1.82122308 |
| 111 | Bulbar palsy (HP:0001283) | 1.81695004 |
| 112 | Cerebral edema (HP:0002181) | 1.80864377 |
| 113 | Congestive heart failure (HP:0001635) | 1.80362165 |
| 114 | Progressive muscle weakness (HP:0003323) | 1.80224638 |
| 115 | Malignant hyperthermia (HP:0002047) | 1.80099129 |
| 116 | Abnormality of the calcaneus (HP:0008364) | 1.69363180 |
| 117 | Sudden cardiac death (HP:0001645) | 1.60873584 |
| 118 | Dysmetric saccades (HP:0000641) | 1.45635055 |
| 119 | Type 2 muscle fiber atrophy (HP:0003554) | 1.42151356 |
| 120 | Popliteal pterygium (HP:0009756) | 1.39070494 |
| 121 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.37794281 |
| 122 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.37794281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.53321118 |
| 2 | OBSCN | 5.44234218 |
| 3 | PHKG2 | 4.70071066 |
| 4 | PHKG1 | 4.70071066 |
| 5 | PDK3 | 3.32564445 |
| 6 | PDK4 | 3.32564445 |
| 7 | LMTK2 | 3.10487018 |
| 8 | MYLK | 2.95732649 |
| 9 | DMPK | 2.91039461 |
| 10 | TRIB3 | 2.57135308 |
| 11 | MUSK | 2.39064976 |
| 12 | PKN2 | 2.30888026 |
| 13 | NEK1 | 2.26204914 |
| 14 | BCKDK | 2.23148178 |
| 15 | PINK1 | 2.21914323 |
| 16 | PIK3CA | 2.19377140 |
| 17 | TIE1 | 2.17538532 |
| 18 | PDK2 | 2.11310075 |
| 19 | STK24 | 1.65049286 |
| 20 | MAP2K3 | 1.40452371 |
| 21 | MARK1 | 1.36155836 |
| 22 | MAP3K7 | 1.35478525 |
| 23 | NME1 | 1.35467408 |
| 24 | GRK7 | 1.30541037 |
| 25 | PIK3CG | 1.24788854 |
| 26 | MAPK12 | 1.20181838 |
| 27 | PRKD1 | 1.12668535 |
| 28 | PAK3 | 1.09126208 |
| 29 | CAMK2D | 1.08659628 |
| 30 | WNK4 | 1.06543141 |
| 31 | ZAK | 1.02390356 |
| 32 | ILK | 1.01913054 |
| 33 | MAPKAPK3 | 0.96627692 |
| 34 | LIMK1 | 0.96364340 |
| 35 | TRPM7 | 0.94401281 |
| 36 | ROCK1 | 0.91083683 |
| 37 | PRKAA1 | 0.89054635 |
| 38 | PRKAA2 | 0.86913873 |
| 39 | EEF2K | 0.82528795 |
| 40 | INSRR | 0.81959570 |
| 41 | MAP3K5 | 0.74545033 |
| 42 | STK38L | 0.74465120 |
| 43 | RIPK1 | 0.74363039 |
| 44 | TGFBR2 | 0.72818752 |
| 45 | PKN1 | 0.71939952 |
| 46 | CCNB1 | 0.70466036 |
| 47 | STK4 | 0.69913865 |
| 48 | EPHB1 | 0.69739557 |
| 49 | MAP3K3 | 0.68105830 |
| 50 | MAP3K6 | 0.67614932 |
| 51 | KDR | 0.64070349 |
| 52 | PDGFRA | 0.63568584 |
| 53 | NEK9 | 0.62824720 |
| 54 | MOS | 0.62402237 |
| 55 | CAMK4 | 0.61169585 |
| 56 | CDC42BPA | 0.58119012 |
| 57 | FLT3 | 0.56192337 |
| 58 | CAMK2B | 0.55918863 |
| 59 | ROCK2 | 0.53290553 |
| 60 | KSR2 | 0.52851811 |
| 61 | ERBB3 | 0.52359948 |
| 62 | CAMK2A | 0.48699254 |
| 63 | PRKACB | 0.47507579 |
| 64 | WNK1 | 0.47302565 |
| 65 | STK38 | 0.45961110 |
| 66 | EPHB2 | 0.45569023 |
| 67 | STK39 | 0.44524218 |
| 68 | CAMK2G | 0.42664617 |
| 69 | DYRK1B | 0.42361981 |
| 70 | RPS6KC1 | 0.41389083 |
| 71 | RPS6KL1 | 0.41389083 |
| 72 | AKT2 | 0.41102521 |
| 73 | LATS1 | 0.40914247 |
| 74 | SGK2 | 0.39728760 |
| 75 | MAP2K6 | 0.37013000 |
| 76 | MAP2K4 | 0.36531743 |
| 77 | DAPK3 | 0.36457080 |
| 78 | SIK1 | 0.35616636 |
| 79 | PDPK1 | 0.35438582 |
| 80 | CAMK1 | 0.35326538 |
| 81 | RPS6KA6 | 0.34674299 |
| 82 | * PRKACA | 0.34643243 |
| 83 | PRKCE | 0.33159488 |
| 84 | PRKACG | 0.32246224 |
| 85 | PTK2B | 0.31845326 |
| 86 | MARK2 | 0.30974739 |
| 87 | PTK6 | 0.29840145 |
| 88 | STK11 | 0.29343440 |
| 89 | NLK | 0.28603558 |
| 90 | TBK1 | 0.26396252 |
| 91 | ICK | 0.26303751 |
| 92 | PDK1 | 0.24793631 |
| 93 | MAP3K13 | 0.24147088 |
| 94 | MAPK10 | 0.23379718 |
| 95 | PRKCH | 0.23344305 |
| 96 | LATS2 | 0.22846211 |
| 97 | MAPK11 | 0.22100875 |
| 98 | BLK | 0.22014317 |
| 99 | PRPF4B | 0.21372535 |
| 100 | PRKG1 | 0.21066902 |
| 101 | RPS6KA1 | 0.21050751 |
| 102 | FER | 0.20613896 |
| 103 | SGK1 | 0.20535354 |
| 104 | MAPK7 | 0.20168086 |
| 105 | DAPK2 | 0.20155147 |
| 106 | JAK1 | 0.20059622 |
| 107 | ZAP70 | 0.19951701 |
| 108 | SGK3 | 0.19013888 |
| 109 | FGFR4 | 0.18715571 |
| 110 | SGK223 | 0.18581791 |
| 111 | SGK494 | 0.18581791 |
| 112 | UHMK1 | 0.18372784 |
| 113 | MTOR | 0.17457473 |
| 114 | RPS6KA3 | 0.16189150 |
| 115 | FGFR3 | 0.14141375 |
| 116 | TAOK1 | 0.13634138 |
| 117 | EPHA3 | 0.13279669 |
| 118 | MARK3 | 0.12047001 |
| 119 | LRRK2 | 0.11228168 |
| 120 | MAP3K11 | 0.10915607 |
| 121 | MAP3K1 | 0.10555255 |
| 122 | RET | 0.09156266 |
| 123 | RPS6KA2 | 0.06696987 |
| 124 | MAPK4 | 0.06501418 |
| 125 | TGFBR1 | 0.06233919 |
| 126 | MAP2K1 | 0.05810537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.81763093 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.27194788 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.15867676 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.07502584 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.03387466 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.21239104 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.19108589 |
| 8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.03048552 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.81962968 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.81933600 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.69826561 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.41379684 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21860043 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.15024197 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.09892670 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.98245589 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.85121990 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.73556407 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.67334801 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67273018 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33522008 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.29578661 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.26369470 |
| 24 | Insulin resistance_Homo sapiens_hsa04931 | 1.25065738 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.21028299 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19800456 |
| 27 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.18074027 |
| 28 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.12691234 |
| 29 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.10421232 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06394980 |
| 31 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06031673 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.99268890 |
| 33 | Focal adhesion_Homo sapiens_hsa04510 | 0.93639089 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.92725284 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.91200752 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.88723271 |
| 37 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.83360137 |
| 38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82727552 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 0.75620376 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75555651 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75435816 |
| 42 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.73658269 |
| 43 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71637964 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70809528 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70545626 |
| 46 | Tight junction_Homo sapiens_hsa04530 | 0.68634425 |
| 47 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68286111 |
| 48 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66465587 |
| 49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65576988 |
| 50 | Long-term potentiation_Homo sapiens_hsa04720 | 0.63352533 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61921958 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56763026 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 0.52351635 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52133394 |
| 55 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49933620 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49663922 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49661511 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49347104 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.48597881 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48578566 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 0.48030067 |
| 62 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47975521 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47936843 |
| 64 | Adherens junction_Homo sapiens_hsa04520 | 0.46696508 |
| 65 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45914658 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43004642 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42612288 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.42086688 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.40113354 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39122606 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38277480 |
| 72 | Insulin secretion_Homo sapiens_hsa04911 | 0.35994357 |
| 73 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34663017 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32998898 |
| 75 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.32762771 |
| 76 | Bile secretion_Homo sapiens_hsa04976 | 0.32686351 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.30533425 |
| 78 | Melanogenesis_Homo sapiens_hsa04916 | 0.28416690 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.26914987 |
| 80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26754197 |
| 81 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.25852784 |
| 82 | GABAergic synapse_Homo sapiens_hsa04727 | 0.24845088 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24137155 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24126689 |
| 85 | Morphine addiction_Homo sapiens_hsa05032 | 0.24028078 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.23257647 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23102432 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.23063592 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.20631653 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19185291 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18918762 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18897668 |
| 93 | Olfactory transduction_Homo sapiens_hsa04740 | 0.18761335 |
| 94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.16800469 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.16454755 |
| 96 | Circadian entrainment_Homo sapiens_hsa04713 | 0.16095118 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.15611147 |
| 98 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.15341970 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.15051369 |
| 100 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.14591292 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.11095432 |
| 102 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.09962378 |
| 103 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.09771137 |
| 104 | Sulfur relay system_Homo sapiens_hsa04122 | 0.09467139 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.08928396 |
| 106 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.08156164 |
| 107 | Gap junction_Homo sapiens_hsa04540 | 0.07557760 |
| 108 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.06868818 |
| 109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.06589121 |
| 110 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.06062257 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.05581830 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.05241957 |
| 113 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.04774078 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.03533697 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.03230096 |
| 116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.01456673 |
| 117 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.01409395 |
| 118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | -0.0173808 |

